SURAKSHA
NSESuraksha Diagnostic Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
₹268.05
0.00 (0.00%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.40K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
44.5
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Service Provider
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹224.1+19.6%
52W High₹352.5-24.0%
Current Price
₹268.05
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹214.44
Upper Circuit₹321.66
Reference Price
₹268.05
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹235.4
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹238.5
Golden Cross detected 1 day(s) ago
Composite score -41.69 (SELL) with 48.3% confidence
Trend: Price below most MAs — downtrend
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
48%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend
EMA20
282.4
EMA50
282.13
EMA200
288.13
Price Action
MIXED
NEUTRAL
Higher Highs2
Higher Lows4
Lower Highs7
Lower Lows5
Support & Resistance Levels
Resistance (Above)
₹273.80
₹278.00
₹286.03
₹294.02
₹311.15
Support (Below)
₹266.17
₹251.50
₹247.05
₹240.00
₹224.10
Volume Analysis
TrendDECREASING
Change-48.30%
Unusual VolumeNo
Recent MA Crossovers
Golden Cross
1 day ago
BUY
Stop Loss Levels
Fixed Risk
1% Risk₹265.37
3% Risk₹260.01
5% Risk₹254.65
7% Risk (Custom)
₹249.29Technical Levels
1x ATR (Volatility)₹255.50
2x ATR (Swing)₹242.95
3x ATR (Trend)₹230.40
Immediate Support₹266.17
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹65.1 Cr | ₹72.6 Cr | ₹78.7 Cr | ₹77.7 Cr |
| Net Profit | ₹7.4 Cr | ₹9.4 Cr | ₹9 Cr | ₹7.5 Cr |
| EPS | — | ₹1.80 | ₹1.73 | ₹1.44 |
| Operating Profit | ₹20 Cr | ₹24.7 Cr | ₹25 Cr | ₹23.8 Cr |
ROE
15.07%
ROCE
16.59%
Debt/Equity
0.42
Current Ratio
1.10
OPM
30.61%
NPM
9.68%
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | ₹1,601.50 | +0.50% |
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| NEPHROPLUS | Nephrocare Health Services Limited | ₹748.15 | -0.42% |
| METROPOLIS | Metropolis Healthcare Limited | ₹530.70 | +2.03% |
| KRSNAA | Krsnaa Diagnostics Limited | ₹534.30 | +0.23% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| HEALTHX | Health X Platform Limited | ₹280.90 | +0.90% |
| CHANDAN | Chandan Healthcare Limited | ₹226.80 | +1.18% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SURAKSHA
View AllNEWS
positive
Business Standard - Markets 22d ago
Suraksha Diagnostic consolidated net profit declines 15.02% in the March 2026 quarter
Sales rise 25.07% to Rs 81.41 crore
SURAKSHAHealthcare
positive
ET Markets - Industry 36d ago
Jan Suraksha revamp: PMJJBY, PMSBY, APY may see increase in sum insured
The government is contemplating a substantial expansion of insurance benefits within its renowned Jan Suraksha initiatives. This strategy is designed to bolster social safety nets for low-income families and informal sector workers.
SURAKSHAHealthcare
positive
CNBC TV18 - Markets 38d ago
SEBI cautions market players on risks from AI tools like Mythos; sets up task force
SEBI warns on AI driven cyber risks, forms cyber-suraksha.ai task force to assess tools like Mythos and strengthen cybersecurity for market participants.
SURAKSHAHealthcare